ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults July 12, 2021 No Comments
Researchers at University of Oxford initiate phase I study of HIVconsvX vaccine July 8, 2021 No Comments
HIV rebound biomarkers give insights into controllers and, unexpectedly, comorbidities July 6, 2021 No Comments
Phase II trial evaluates ImmunityBio Anktiva with ART to inhibit HIV reservoirs April 30, 2021 No Comments
Study to assess analytical treatment interruption in participants who contracted HIV in VRC-01 trial April 6, 2021 No Comments
RSS